Alcoholic liver disease by Sunil Kumar Daha

17,734 views 28 slides Jun 18, 2018
Slide 1
Slide 1 of 28
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28

About This Presentation

please find the powerpooint presentation on Alcoholic liver disease presented by sunil kumar daha (me) and my friend Bishnu Ranjan Patel.


Slide Content

Alcoholic Liver Disease Presented by: Bishanu Ranjan Patel Sunil Kumar Daha

Introduction Hepatic manifestations of alcoholic over consumption. Fatty liver Alcoholic Hepatitis Alcoholic cirrhosis ALD doesn’t occur below a threshold of alcohol consumption of :- <14units/week in women <21units/week in men Alcoholics vs ALD 1 unit-8 gm

Risk factors Quantity of alcohol In men, 40–80 g/d of ethanol produces fatty liver; in women, 20-40 g/d is enough 160 g/d for 10–20 years causes hepatitis or cirrhosis Drinking pattern: Continuous vs. intermittent Gender: Female twice > men Genetics: Monozygotic twins Vs. dizygotic Nutrition Obesity Malnutrition specially choline-deficient diet Hepatitis C infection

Amount of alcohol in average drink Alcohol type % alcohol by volume Amount Units Beer 3.5 9 440 ml 440 ml 2 4 Wine 10 12 125 ml 750 ml 1 9 Alcopops 6 330 ml 2 Sherry 17.5 750 ml 13 Vodka/rum/gin 37.5 25 ml 1 Whisky/brandy 40 700 ml 28 Ref: Devidson’s 22 nd edition

Metabolism of Alcohol Ethanol(80%) Acetaldehyde Acetyl co-A and Acetate Ethanol(20%) Acetate Alcohol is metabolized in liver via 2 pathways :- NAD NADH Cyt CYP2E1 Alcohol dehydrogenase Aldehyde dehydrogenase

Pathogenesis

M alondialdehyde acetaldehyde

Pathological changes

1. Alcoholic fatty liver Accumulation of triglycerides within hepatocytes Can be reversed if alcohol consumption is stopped or reduced significantly Has a good prognosis, disappears after 3 months of abstinence

2. Alcoholic Hepatitis Hepatocyte injury is characterized by- Mallorys Hyaline, Centrilobular necrosis, Fatty change, Hepatocyte ballooning, PMN infiltrate, Pericellular fibrosis Worse prognosis than fatty liver disease Precursors to cirrhosis Potentially reversible with alcohol abstinence

3. Alcoholic Liver cirrhosis “A condition in which there is continuing fibrosis resulting in the subdivision of the liver into nodules of proliferating hepatocytes surrounded by scar tissue as the direct result of chronic alcohol abuse.” Irreversible condition even with abstinence Present in up to 50% of patients with biopsy-proven alcoholic hepatitis

Contd… Vicious circle of Chronic inflammation Fibrosis Nodular regeneration D istortion of architecture Hepatocellular necrosis

Clinical syndromes of Alcoholic Liver Diseases Fatty Liver Alcoholic hepatitis Cirrhosis Asymptomatic Abnormal liver biochemistry Normal or large liver RUQ discomfort Nausea Rarely jaundice Asymptomatic Jaundice Malnutrition Hepatomegaly Features of portal hypertension e.g. ascites encephalopathy Stigmata of chronic liver diseases Ascites/varices/encephalopathy Large, normal or small liver Hepatocellular carcinoma

Investigations Macrocytosis in the absence of anaemia, may suggest and support a history of alcohol misuse Unexplained rib fractures, particularly bilateral, on a chest X-ray are also suggestive of alcohol misuse Presence of jaundice suggests alcoholic hepatitis Test Comment AST Increased two- to seven fold , <400 U/L, greater than ALT ALT Increased two- to sevenfold, <400 U/L AST/ALT Usually >1 GGTP Not specific to alcohol, easily inducible, elevated in all forms of fatty liver Bilirubin May be markedly increased in alcoholic hepatitis despite modest elevation in alkaline phosphatase PT Prolonged Albumin Hypoalbuminemia PMN If>5500 /ml Predicts severe alcoholic hepatitis when discriminant function > 32

Contd… We can also send for: Ultrasonography: fatty infiltration and determine liver size portal vein flow reversal, ascites, and intra-abdominal collaterals  indicates serious liver injury with less potential for complete reversal of liver disease Liver Biopsy:

Prognosis Critically ill patients with alcoholic hepatitis have short-term (30-day) mortality rates >50% Presence of ascites, variceal hemorrhage, deep encephalopathy, or hepatorenal syndrome predicts a dismal prognosis Pathologic stage of the injury by liver biopsy

Discriminant Function (DF) Aka ‘ Maddrey score’ DF = (4.6 x increase in PT sec. )) + (serum bilirubin mg/dl) To assess prognosis in alcoholic hepatitis A value over 32 implies severe liver disease with a poor prognosis

Glasgow Alcoholic Hepatitis Score Score 1 2 3 Age < 50 > 50   WCC (× 10 9 /L) < 15 > 15 > 2.0 Urea (mmol/L) < 5 > 5 > 250 PT ratio < 1.5 1.5-2.0   Bilirubin ( μ mol/L) < 125 125-250   A score > 9 is associated with a 40% 28-day survival, compared to 80% for patients with a score < 9

Model for End-stage Liver Disease (MELD)   1-year survival (%) MELD score No complications Complications < 9 97 90 10-19 90 85 20-29 70 65 30-39 70 50 MELD from SI units 10 × (0.378[In serum bilirubin (μmol/L) + 1.12[In INR] + 0.957[In serum creatinine (μmol/L)] + 0.643) MELD from non-SI units 3.8 [In serum bilirubin (mg/dL)] + 11.2 [In INR] + 9.3 [In serum creatinine (mg/dL)] + 6.4

Management Alcohol Abstinence Nutritional Support Corticosteroid Therapy Pentoxifylline Liver Transplantation * We also have to manage for :- Alcohol withdrawal and Wernicke's encephalopathy Treatment for complications of cirrhosis, such as variceal bleeding, encephalopathy and ascites

1. Alcohol abstinence Most important treatment of all Effective in preventing progression of disease Alcohol withdrawal syndrome and Wernicke’s encephalopathy need parallel treatment too

2. Nutritional support Protein supplementation Vit A Folate Vit B6 Thiamine

3. Corticosteroids Glucocorticoids have been found to be beneficial in patients with severe alcoholic hepatitis ( Maddrey’s DF score ≥32). Survival rate found to be increased in those with Glasgow score >9 Sepsis is the main side effect Should not be given to patients with active GI bleeding, sepsis, renal failure or pancreatitis.

4. Pentoxifylline Anti- TNF action Reduce incidence of hepato -renal failure Given in severe alcoholic hepatitis in whom corticosteroids cannot be given

References Harrison’s Principle of Medicine, 19 th edition Davidson’s Principle and Practice of Medicine, 22nd edition Kumar and Clark’s Clinical Medicine, 8th edition

Thank You!